XML 22 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMITMENTS AND CONTINGENCIES (Details) (USD $)
In Thousands, unless otherwise specified
1 Months Ended
Jun. 30, 2012
Dec. 31, 2011
Bank guarantee in favor of lessor for offices in Israel $ 91  
Aggregate contingent obligation for payments to Office of the Chief Scientist 8,565  
Cash consideration paid for access right to Antibody Technology 600  
Portion of cash consideration paid for access right to Antibody Technology recorded to noncurrent prepaid expense 400   
Number of years company has access right to Technology 3  
Additional (maximum cumulative) cash consideration to be paid for right of use of Antibody Technology upon occurance of certain development and commercialization milestones $ 3,250  
Maximum [Member]
   
Percentage of sales committed to pay royalties 5.00%  
Minimum [Member]
   
Percentage of sales committed to pay royalties 3.00%